Standout Papers

Combination strategies with PD-1/PD-L1 blockade: cur... 2018 2026 2020 2023 827
  1. Combination strategies with PD-1/PD-L1 blockade: current advances and future directions (2022)
    Ming Yi, Xiaoli Zheng et al. Molecular Cancer
  2. Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4 (2019)
    Shuang Qin, Linping Xu et al. Molecular Cancer
  3. Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors (2018)
    Ming Yi, Dechao Jiao et al. Molecular Cancer
  4. Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment (2019)
    Ming Yi, Dechao Jiao et al. Molecular Cancer
  5. Regulation of PD-L1 expression in the tumor microenvironment (2021)
    Ming Yi, Mengke Niu et al. Journal of Hematology & Oncology
  6. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy (2019)
    Anping Li, Ming Yi et al. Journal of Hematology & Oncology
  7. Polyamide-based membranes with structural homogeneity for ultrafast molecular sieving (2022)
    Liang Shen, Ruihuan Cheng et al. Nature Communications
  8. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy (2022)
    Yuze Wu, Ming Yi et al. Molecular Cancer
  9. Recent advances in targeted strategies for triple-negative breast cancer (2023)
    Shuangli Zhu, Yuze Wu et al. Journal of Hematology & Oncology
  10. Exploiting innate immunity for cancer immunotherapy (2023)
    Ming Yi, Tianye Li et al. Molecular Cancer
  11. Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021 (2025)
    Tianye Li, Haoxiang Zhang et al. Journal of Hematology & Oncology
  12. Tailoring traditional Chinese medicine in cancer therapy (2025)
    Xi Chen, Hui Shi et al. Molecular Cancer

Immediate Impact

1 by Nobel laureates 24 from Science/Nature 53 standout
Sub-graph 1 of 23

Citing Papers

Cancer immune evasion, immunoediting and intratumour heterogeneity
2025 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
5 intermediate papers

Works of Ming Yi being referenced

Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy
2023
Exploiting innate immunity for cancer immunotherapy
2023 Standout
and 6 more

Author Peers

Author Last Decade Papers Cites
Ming Yi 4518 2934 2942 148 9.4k
Wen Jiang 2569 3113 2367 262 10.5k
Akira Yamauchi 1869 3056 4113 282 8.9k
Shuang Wei 4931 3001 6643 93 11.6k
Lei Zheng 1234 7626 1151 410 13.1k
John W. Smith 2294 1828 1591 152 6.0k
Zhenping Zhu 4015 8097 1581 168 15.0k
Suk Woo Nam 2045 5942 653 407 14.5k
Robert Damoiseaux 1499 2860 1213 145 7.9k
Min Shi 915 2588 567 199 7.7k
Kihyun Kım 3252 2267 1118 384 7.8k

All Works

Loading papers...

Rankless by CCL
2026